Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma.

Nornazirah AzizanFirdaus HayatiNur Maya Sabrina TizenWirda Indah FaroukNoraidah Masir

Published in: Investigative and clinical urology (2018)

ER-beta and Ki67 are independent tumor markers in high prognostic groups. Hence, co-expression of ER-beta and Ki67 indicates a more aggressive tumor with a poorer prognosis.

Keyphrases

estrogen receptor
poor prognosis
neoadjuvant chemotherapy
prostate cancer
squamous cell carcinoma
binding protein
long non coding rna
locally advanced
endoplasmic reticulum
radiation therapy
benign prostatic hyperplasia